June 2015
Volume 56, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2015
Classification of myopic choroidal neovascularization by fluorescein angiography and optical coherence tomography
Author Affiliations & Notes
  • Hyunseung Kang
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Hyoung Eun Kim
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Jin Hae Lee
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Dongkyu Lee
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Hyun-Sub Oh
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Yong Sung You
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Soon Hyun Kim
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Oh Woong Kwon
    Vitreoretinal, Nune Eye Hospital, Seoul, Korea (the Republic of)
  • Footnotes
    Commercial Relationships Hyunseung Kang, None; Hyoung Eun Kim, None; Jin Hae Lee, None; Dongkyu Lee, None; Hyun-Sub Oh, None; Yong Sung You, None; Soon Hyun Kim, None; Oh Woong Kwon, None
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2015, Vol.56, 3757. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hyunseung Kang, Hyoung Eun Kim, Jin Hae Lee, Dongkyu Lee, Hyun-Sub Oh, Yong Sung You, Soon Hyun Kim, Oh Woong Kwon; Classification of myopic choroidal neovascularization by fluorescein angiography and optical coherence tomography. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):3757.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose: To describe morphologic features of myopic choroidal neovascularization (mCNV) on fluorescein angiography (FA) and spectral-domain optical coherence tomography (SD OCT), as well as to correlate them with treatment response.

Methods: Sixty-eight eyes of 65 patients with mCNV were included in a retrospective, interventional case series. The images of FA and OCT, and various clinical parameters were examined. mCNV was classified on the basis of FA and OCT findings. The clinical parameters were compared between the types, and correlated with visual acuity.

Results: mCNV was classified into two categories: I, with leakage throughout all phases on FA and definite subretinal thickening on OCT (42 patients), and II, with leakage only on late phase of FA and mild subretinal thickening on OCT (23 patients). Besides age, other clinical parameters such as axial length showed no significant difference between the two types. With mean follow-up of 24 months, type I received a mean of 5.3±3.3 anti-VEGF injections whereas type II received a mean of 6.6±4.4 injections (P=0.171). However, visual improvement after anti-VEGF therapy was statistically significant in type I, but not in type II (+0.19 logMAR, P=0.004 vs. +0.10 logMAR, P=0.183).

Conclusions: mCNV can be classified into two types according to FA and OCT findings. Each type showed different response to anti-VEGF therapy, suggesting that the classification of mCNV may yield important insights into treatment strategy and predicting prognosis.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×